Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, AMENDED Notice of Meetings, 161-162 [2019-28282]

Download as PDF 161 lotter on DSKBCFDHB2PROD with NOTICES Federal Register / Vol. 85, No. 1 / Thursday, January 2, 2020 / Notices driveways into the project site would include two clear-span bridges crossing the City Creek Bypass Channel; Construction of Third Street modifications to tie-in road gradients and turning lanes with bridge entrances; Installation of new security fencing, vehicle and pedestrian gates and a guard shack; Installation of pole-mounted and/ or building-mounted exterior lights for vehicle and truck parking lots, Air Cargo Sort Building, and aircraft parking apron; Installation of appropriate airfield lights and signage for the aircraft parking apron and taxilanes; Land clearing, demolition, excavation, embankment, and grading; Extension of utilities to the Proposed Project including electrical, natural gas, water, sanitary sewer, communications, and other related infrastructure; Installation of stormwater management systems and infrastructure; landscaping, Project Commitment 1: Require Use of Electric Ground Support Equipment. With the exception of the fuel trucks and lavatory service trucks, which are assumed to operate on diesel fuel, the SBIAA will require the use of ground support equipment that can operate on electric battery power, and Project Commitment 2: Construct a Second Eastbound Left Turn Land and a Second Westbound Left Turn Lane at Victoria Avenue and Third Street. SBIAA shall be responsible for constructing a second eastbound left turn land and a second westbound left turn late at Victoria Avenue. and Third Street. Copies of the Final EA and FONSI/ ROD are available for public review at the following locations during normal business hours: • U.S. Department of Transportation, Federal Aviation Administration, Western-Pacific Region, Office of Airports, 777 S. Aviation Boulevard, Suite 150, El Segundo, California 90245 • San Bernardino International Airport Authority Administration Offices, 1601 East Third Street, San Bernardino, California 92408 The Final EA may be viewed at San Bernardino International Airport’s website: https://www.sbiaa.org/. The FONSI and ROD may also be viewed at FAA’s website: https:// www.faa.gov/airports/environmental/ records_decision/ and the SBIAA’s website. Copies of the Final EA and FONSI and ROD are also available at the following libraries: • Highland Sam J. Racadio Branch Public Library and Environmental Learning Center, 7863 Central Ave, Highland, California 92346 • San Bernardino County Library, Lake Arrowhead Branch, 27235 Highway 189, Blue Jay, California 92317 • Norman F. Feldheym Public Library, 555 W 6th St., San Bernardino, California 92410 Questions on the Final EA and FONSI/ROD may be directed to the individual above under the heading FOR FURTHER INFORMATION CONTACT. Issued in El Segundo, California on December 23, 2019. Mark A. McClardy, Director, Office of Airports, Western—Pacific Region, AWP–600. [FR Doc. 2019–28346 Filed 12–31–19; 8:45 am] BILLING CODE 4910–13–P DEPARTMENT OF TRANSPORTATION Federal Railroad Administration Restoration and Enhancement Grants Program Federal Railroad Administration (FRA), Department of Transportation (DOT). ACTION: Notice of Funding Opportunity (NOFO or notice); extension and supplemental funding notice. AGENCY: FRA is adding funding to and extending the application submittal period for its NOFO for the Restoration and Enhancement Grants Program (R&E Program) published on November 6, 2019. The basis for the funding increase and extension is the appropriation of additional amounts for the Restoration and Enhancement Grants Program in Fiscal Year 2020 together with the government’s goal of efficiently administering such funds. DATES: The original due date for applications was January 6, 2020. The period for submitting applications to the NOFO published on November 6, 2019 (84 FR 59907) https://www.govinfo.gov/ content/pkg/FR-2019-11-06/pdf/201924225.pdf, is extended. Applications must now be submitted by 5:00 p.m. eastern on February 5, 2020. FOR FURTHER INFORMATION CONTACT: For further information regarding the R&E Program and projects, please contact Ruthie Americus, Office of Policy and Planning, Federal Railroad SUMMARY: Administration,1200 New Jersey Avenue SE, Room W36–403, Washington, DC 20590; email: ruthie.americus@dot.gov; phone: 202– 493–0431. Grant application submission and processing questions should be addressed to Amy Houser, Office of Program Delivery, Federal Railroad Administration, 1200 New Jersey Avenue SE, Room W36–412, Washington, DC 20590; email: amy.houser@dot.gov; phone: 202–493– 0303. SUPPLEMENTARY INFORMATION: Amendment FRA amends its NOFO for the Restoration and Enhancement Grants Program published on November 6, 2019 (84 FR 59907) https:// www.govinfo.gov/content/pkg/FR-201911-06/pdf/2019-24225.pdf by: (1) Adding an additional $1,918,600 for a total of $26,337,600 and (2) extending the period for submitting applications to February 5, 2020. Issued in Washington, DC. Ronald L. Batory, Administrator, Federal Railroad Administration. [FR Doc. 2019–28305 Filed 12–31–19; 8:45 am] BILLING CODE 4910–06–P DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, AMENDED Notice of Meetings The Department of Veterans Affairs (VA) gives notice under Federal Advisory Committee Act that the subcommittees of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board (JBL/CS SMRB) will be held on the dates below from 8:00 a.m. to 5:00 p.m. (unless otherwise listed) at the 20 F Conference Center, 20 F Street NW, Washington, DC 20001, the Phoenix Park Hotel, 520 North Capitol Street NW, Washington, DC 20001, and at the Office of Research and Development, 1100 First Street NE, Washington, DC 20002: Meeting Date(s) BL/CS R&D Surgery Subcommittee .............................................................................................................................. BL/CS R&D Pulmonary Medicine Subcommittee .......................................................................................................... BL/CS R&D Infectious Diseases-B Subcommittee ....................................................................................................... VerDate Sep<11>2014 17:39 Dec 31, 2019 Jkt 250001 PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 E:\FR\FM\02JAN1.SGM 02JAN1 November 12, 2019. November 13, 2019. November 14, 2019. 162 Federal Register / Vol. 85, No. 1 / Thursday, January 2, 2020 / Notices Meeting Date(s) BL/CS R&D Oncology-A/D Subcommittee .................................................................................................................... BL/CS R&D Hematology Subcommittee ....................................................................................................................... BL/CS R&D Oncology-C Subcommittee ....................................................................................................................... BL/CS R&D Cellular & Molecular Medicine Subcommittee .......................................................................................... BL/CS R&D Oncology-B/E Subcommittee .................................................................................................................... BL/CS R&D Mental Health & Behavioral Sciences-P ................................................................................................... BL/CS R&D Immunology & Dermatology-A Subcommittee .......................................................................................... BL/CS R&D Mental Health & Behavioral Sciences-C Subcommittee ........................................................................... BL/CS R&D Cardiovascular Studies-A Subcommittee .................................................................................................. BL/CS R&D Endocrinology-A Subcommittee ................................................................................................................ BL/CS R&D Neurobiology-C Subcommittee ................................................................................................................. BL/CS R&D Neurobiology-E Subcommittee .................................................................................................................. BL/CS R&D Endocrinology-B Subcommittee ................................................................................................................ BL/CS R&D Mental Health & Behavioral Sciences-A Subcommittee ........................................................................... BL/CS R&D Nephrology Subcommittee ........................................................................................................................ BL/CS R&D Neurobiology-B Subcommittee .................................................................................................................. BL/CS R&D Infectious Diseases-A Subcommittee ....................................................................................................... BL/CS R&D Neurobiology-F Subcommittee .................................................................................................................. BL/CS R&D Cardiovascular Studies-B Subcommittee .................................................................................................. BL/CS R&D Gastroenterology Subcommittee ............................................................................................................... BL/CS R&D Neurobiology-P Subcommittee .................................................................................................................. BL/CS R&D Neurobiology-R Subcommittee ................................................................................................................. BL/CS R&D Neurobiology-A Subcommittee .................................................................................................................. BL/CS R&D Neurobiology-D Subcommittee ................................................................................................................. BL/CS R&D Gulf War Research Subcommittee ........................................................................................................... BL/CS R&D VA Psychiatrist Development Award Subcommittee ................................................................................ Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board. BL/CS R&D Eligibility Subcommittee ............................................................................................................................ lotter on DSKBCFDHB2PROD with NOTICES The purpose of the subcommittees is to provide advice on the scientific quality, budget, safety and mission relevance of investigator-initiated research proposals submitted for VA merit review evaluation. Proposals submitted for review include various medical specialties within the general areas of biomedical, behavioral and clinical science research. The subcommittee meetings will be closed to the public for the review, discussion, and evaluation of initial and renewal research proposals. However, the JBL/CS SMRB teleconference meeting will be open to the public. Members of the public who wish to attend the open JBL/CS SMRB teleconference may dial 1–800–767– 1750, participant code 50064#. Members of the public who wish to make a VerDate Sep<11>2014 17:39 Dec 31, 2019 Jkt 250001 statement at the JBL/CS SMRB meeting must notify Dr. Holly Krull via email at holly.krull@va.gov by January 6, 2020. These subcommittee meetings will be closed to the public for the review, discussion, and evaluation of initial and renewal research proposals, which involve reference to staff and consultant critiques of research proposals. Discussions will deal with scientific merit of each proposal and qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Additionally, premature disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals. As provided by subsection 10(d) of Public Law 92–463, as amended PO 00000 Frm 00100 Fmt 4703 Sfmt 9990 November 14, 2019. November 15, 2019. November 15, 2019. November 18, 2019. November 18, 2019. November 19, 2019. November 20, 2019. November 20, 2019. November 21, 2019. November 21, 2019. November 21, 2019. November 22, 2019. November 25, 2019. December 3, 2019. December 3, 2019. December 3, 2019. December 4, 2019. December 4, 2019. December 5, 2019. December 5, 2019. December 5, 2019. December 5, 2019. December 6, 2019. December 6, 2019. December 6, 2019. January 8, 2020. January 8, 2020. January 17, 2020. by Public Law 94–409, closing the subcommittee meetings is in accordance with Title 5 U.S.C. 552b(c)(6) and (9)(B). Those who would like to obtain a copy of the minutes from the closed subcommittee meetings and rosters of the subcommittee members should contact Holly Krull, Ph.D., Manager, Merit Review Program (10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC 20420, at (202) 632–8522 or email at holly.krull@va.gov. Dated: December 27, 2019. Jelessa M. Burney, Federal Advisory Committee Management Officer. [FR Doc. 2019–28282 Filed 12–31–19; 8:45 am] BILLING CODE P E:\FR\FM\02JAN1.SGM 02JAN1

Agencies

DEPARTMENT OF VETERANS AFFAIRS

[Federal Register Volume 85, Number 1 (Thursday, January 2, 2020)]
[Notices]
[Pages 161-162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28282]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board, AMENDED Notice of Meetings

    The Department of Veterans Affairs (VA) gives notice under Federal 
Advisory Committee Act that the subcommittees of the Joint Biomedical 
Laboratory Research and Development and Clinical Science Research and 
Development Services Scientific Merit Review Board (JBL/CS SMRB) will 
be held on the dates below from 8:00 a.m. to 5:00 p.m. (unless 
otherwise listed) at the 20 F Conference Center, 20 F Street NW, 
Washington, DC 20001, the Phoenix Park Hotel, 520 North Capitol Street 
NW, Washington, DC 20001, and at the Office of Research and 
Development, 1100 First Street NE, Washington, DC 20002:

------------------------------------------------------------------------
                     Meeting                              Date(s)
------------------------------------------------------------------------
BL/CS R&D Surgery Subcommittee..................  November 12, 2019.
BL/CS R&D Pulmonary Medicine Subcommittee.......  November 13, 2019.
BL/CS R&D Infectious Diseases-B Subcommittee....  November 14, 2019.

[[Page 162]]

 
BL/CS R&D Oncology-A/D Subcommittee.............  November 14, 2019.
BL/CS R&D Hematology Subcommittee...............  November 15, 2019.
BL/CS R&D Oncology-C Subcommittee...............  November 15, 2019.
BL/CS R&D Cellular & Molecular Medicine           November 18, 2019.
 Subcommittee.
BL/CS R&D Oncology-B/E Subcommittee.............  November 18, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-P.  November 19, 2019.
BL/CS R&D Immunology & Dermatology-A              November 20, 2019.
 Subcommittee.
BL/CS R&D Mental Health & Behavioral Sciences-C   November 20, 2019.
 Subcommittee.
BL/CS R&D Cardiovascular Studies-A Subcommittee.  November 21, 2019.
BL/CS R&D Endocrinology-A Subcommittee..........  November 21, 2019.
BL/CS R&D Neurobiology-C Subcommittee...........  November 21, 2019.
BL/CS R&D Neurobiology-E Subcommittee...........  November 22, 2019.
BL/CS R&D Endocrinology-B Subcommittee..........  November 25, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-A   December 3, 2019.
 Subcommittee.
BL/CS R&D Nephrology Subcommittee...............  December 3, 2019.
BL/CS R&D Neurobiology-B Subcommittee...........  December 3, 2019.
BL/CS R&D Infectious Diseases-A Subcommittee....  December 4, 2019.
BL/CS R&D Neurobiology-F Subcommittee...........  December 4, 2019.
BL/CS R&D Cardiovascular Studies-B Subcommittee.  December 5, 2019.
BL/CS R&D Gastroenterology Subcommittee.........  December 5, 2019.
BL/CS R&D Neurobiology-P Subcommittee...........  December 5, 2019.
BL/CS R&D Neurobiology-R Subcommittee...........  December 5, 2019.
BL/CS R&D Neurobiology-A Subcommittee...........  December 6, 2019.
BL/CS R&D Neurobiology-D Subcommittee...........  December 6, 2019.
BL/CS R&D Gulf War Research Subcommittee........  December 6, 2019.
BL/CS R&D VA Psychiatrist Development Award       January 8, 2020.
 Subcommittee.
Joint Biomedical Laboratory Research and          January 8, 2020.
 Development and Clinical Science Research and
 Development Services Scientific Merit Review
 Board.
BL/CS R&D Eligibility Subcommittee..............  January 17, 2020.
------------------------------------------------------------------------

    The purpose of the subcommittees is to provide advice on the 
scientific quality, budget, safety and mission relevance of 
investigator-initiated research proposals submitted for VA merit review 
evaluation. Proposals submitted for review include various medical 
specialties within the general areas of biomedical, behavioral and 
clinical science research.
    The subcommittee meetings will be closed to the public for the 
review, discussion, and evaluation of initial and renewal research 
proposals. However, the JBL/CS SMRB teleconference meeting will be open 
to the public. Members of the public who wish to attend the open JBL/CS 
SMRB teleconference may dial 1-800-767-1750, participant code 50064#. 
Members of the public who wish to make a statement at the JBL/CS SMRB 
meeting must notify Dr. Holly Krull via email at [email protected] by 
January 6, 2020.
    These subcommittee meetings will be closed to the public for the 
review, discussion, and evaluation of initial and renewal research 
proposals, which involve reference to staff and consultant critiques of 
research proposals. Discussions will deal with scientific merit of each 
proposal and qualifications of personnel conducting the studies, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy. Additionally, premature disclosure of research 
information could significantly obstruct implementation of proposed 
agency action regarding the research proposals. As provided by 
subsection 10(d) of Public Law 92-463, as amended by Public Law 94-409, 
closing the subcommittee meetings is in accordance with Title 5 U.S.C. 
552b(c)(6) and (9)(B).
    Those who would like to obtain a copy of the minutes from the 
closed subcommittee meetings and rosters of the subcommittee members 
should contact Holly Krull, Ph.D., Manager, Merit Review Program 
(10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, 
Washington, DC 20420, at (202) 632-8522 or email at [email protected].

    Dated: December 27, 2019.
Jelessa M. Burney,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-28282 Filed 12-31-19; 8:45 am]
BILLING CODE P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.